Age, yr, mean ± SD | 36.4 ± 17.6 |
Sex, female | 75 (65) |
Education, university | 109 (94) |
Canadian-born | 92 (79) |
Premorbid conditions | |
Diabetes mellitus | 4 (3) |
Urinary tract infection (< 1 yr before travel) | 8 (7) |
Other | 5 (4) |
Medications (6 mo before travel) | |
Antibiotics | 13 (11) |
Other | 22 (19) |
Contact with health care system (6 mo before travel) |
Without hospital admission | 23 (20) |
With hospital admission | 0 |
Residence, rural | 4 (3) |
Pets in home | 47 (40) |
Travel within previous 6 mo | 27 (23) |
Duration of current travel, d, range | 10-38 |
ESBL-producing E. coli before travel | |
Yes | 7 (6) |
No | 109 (94) |
Travel destination†‡ |
India | 90 (83) |
Nepal (Kathmandu, Bhaktapur, Pokhara) | 9 (8) |
Pakistan (Lahore) | 1 (1) |
Bangladesh (Dhaka) | 1 (1) |
Sri Lanka (Colombo, Kandy, Galle) | 8 (7) |
Reason for travel‡ |
Tourism | 93 (85) |
Visiting friends and relatives | 4 (4) |
Business | 12 (11) |
With ESBL-producing E. coli after travel‡ | 70 (64) |
To India (n = 90) | 66 (73) |
To Nepal (n = 9) | 2 (22) |
To Pakistan (n = 1) | 1 (100) |
To Bangladesh (n = 1) | 1 (100) |
To Sri Lanka (n = 8) | 0 |